Published in J Cytol Mol Biol on January 10, 2014
Macrophage immunoregulatory pathways in tuberculosis. Semin Immunol (2014) 0.88
From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity. Nat Rev Drug Discov (2015) 0.85
Schistosome Soluble Egg Antigen Decreases Mycobacterium tuberculosis-Specific CD4+ T-Cell Effector Function With Concomitant Arrest of Macrophage Phago-Lysosome Maturation. J Infect Dis (2016) 0.79
Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of amphotericin B: formulation development and in vitro and in vivo evaluation. Antimicrob Agents Chemother (2015) 0.78
γ-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206). J Immunol (2015) 0.78
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach. Nucl Med Biol (2015) 0.76
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance. Clin Immunol (2015) 0.76
Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A. Infect Immun (2015) 0.76
Nanomedicines for dysfunctional macrophage-associated diseases. J Control Release (2017) 0.75
Modulation of Macrophage Responses by CMX, a Fusion Protein Composed of Ag85c, MPT51, and HspX from Mycobacterium tuberculosis. Front Microbiol (2017) 0.75
Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice. Sci Rep (2017) 0.75
Recognition of microorganisms and activation of the immune response. Nature (2007) 12.99
Macrophage biology in development, homeostasis and disease. Nature (2013) 8.28
Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling. Cell (1980) 5.95
Macrophage receptors and immune recognition. Annu Rev Immunol (2005) 5.83
The origin and function of tumor-associated macrophages. Immunol Today (1992) 5.12
Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol (1993) 4.23
Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov (2013) 3.50
Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science (2007) 3.27
Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog (2008) 3.02
Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science (2002) 2.75
The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med (2005) 2.50
Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases. Emerg Infect Dis (2005) 2.30
The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity (1997) 2.07
Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J Immunol (2013) 1.62
Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions. Antimicrob Agents Chemother (2011) 1.50
The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol (2005) 1.45
A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. J Nucl Med (2001) 1.42
Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. J Immunol (2010) 1.37
From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Crit Rev Immunol (2004) 1.27
Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity. Am J Pathol (1996) 1.26
Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages. Cancer Res (2012) 1.20
A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol (2005) 1.17
Mannose receptor-targeted vaccines. Expert Opin Biol Ther (2004) 1.16
Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. J Immunol (2004) 1.12
Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages. Clin Dev Immunol (2011) 1.07
Role of C-type lectins in mycobacterial infections. Curr Drug Targets (2008) 1.06
Macrophages in tuberculosis: friend or foe. Semin Immunopathol (2013) 1.04
Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther (2000) 1.02
PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes. Biomaterials (2012) 1.02
Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells. Mol Pharm (2011) 1.01
Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles. Mol Pharm (2013) 0.98
Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Mol Pharm (2013) 0.97
SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis. J Nucl Med (2013) 0.97
Binding properties of the mannose receptor. Immunobiology (2001) 0.96
Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers. J Control Release (2013) 0.95
Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using "pathogen-like" amphiphilic polyanhydride nanoparticles. Biomaterials (2012) 0.92
Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer. Cancer Sci (2010) 0.91
Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes. Biomaterials (2007) 0.85
Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides. J Immunol (2013) 0.82
Novel monodisperse PEGtide dendrons: design, fabrication, and evaluation of mannose receptor-mediated macrophage targeting. Bioconjug Chem (2013) 0.81
Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration. J Gene Med (2006) 0.81
Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery. Nanomedicine (2011) 0.79
Liposomes as potential carrier system for targeted delivery of polyene antibiotics. Recent Pat Inflamm Allergy Drug Discov (2013) 0.77